|
9
|
6-minute walking distance (6-MWD) |
isolated CHD: CHD with PAH |
protective factor |
|
10
|
NT‐proBNP |
isolated CHD: CHD with PAH |
protective factor |
|
21
|
depression score (≥3) |
isolated CHD/non-isolated CHD: TAPVR/ASD/VSD/AVSD/CoA/TGA/ccTGA/CACA/DORV, DILV/EA/PDA/PVD/TA/TOF/other |
protective factor |
|
22
|
delayed sleep onset |
isolated CHD/non-isolated CHD: TAPVR/ASD/VSD/AVSD/CoA/TGA/ccTGA/CACA/DORV, DILV/EA/PDA/PVD/TA/TOF/other |
protective factor |
|
23
|
nocturnal awakenings |
isolated CHD/non-isolated CHD: TAPVR/ASD/VSD/AVSD/CoA/TGA/ccTGA/CACA/DORV, DILV/EA/PDA/PVD/TA/TOF/other |
protective factor |
|
37
|
Cord blood BNP |
NA: NA |
protective factor |
|
39
|
Cord blood BNP |
NA: NA |
protective factor |
|
67
|
outcome of ischemic placental disease |
isolated CHD: Anomalies of venous return |
protective factor |
|
68
|
outcome of ischemic placental disease |
non-isolated CHD: Anomalies of the atria and interatrial communications |
protective factor |
|
69
|
outcome of ischemic placental disease |
non-isolated CHD: Anomalies of atrioventricular junctions and valves |
protective factor |
|
92
|
gestational age at delivery with cardiac complication |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ASD, VSD/ASD, PDA/VSD, PDA/VSD, ES/PDA, ES/VSD, CHD with PAH |
protective factor |
|
95
|
lower SaO2 |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/ASD, VSD/ASD, PDA/VSD, PDA/VSD, ES/PDA, ES/VSD, CHD with PAH |
protective factor |
|
159
|
higher maternal total fat intake |
isolated CHD/non-isolated CHD: DIVM/DIVM, other |
protective factor |
|
221
|
seraphin(duration of drug administration) |
isolated CHD: ASD/VSD/PTA |
protective factor |
|
225
|
6-MWD |
isolated CHD: CHD with PAH |
protective factor |
|
337
|
5-year mortality |
isolated CHD/non-isolated CHD: VSD/VSD, PDA/CoA/CAVC/DORV |
protective factor |
|
358
|
executive dysfunction-direct effect on QOL |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PS/TA/VSD/TA, IAA/VSD, CoA/CoA, AH/PS, IVS/SV/HLHS/SV, AO |
protective factor |
|
359
|
Aortic obstruction-indirect effect on QOL |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PS/TA/VSD/TA, IAA/VSD, CoA/CoA, AH/PS, IVS/SV/HLHS/SV, AO |
protective factor |
|
360
|
premature birth-indirect effect on QOL |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PS/TA/VSD/TA, IAA/VSD, CoA/CoA, AH/PS, IVS/SV/HLHS/SV, AO |
protective factor |
|
361
|
male sex-indirect effect on QOL |
isolated CHD/non-isolated CHD: D-TGA, IVS/D-TGA, VSD/TOF/TOF, PS/TA/VSD/TA, IAA/VSD, CoA/CoA, AH/PS, IVS/SV/HLHS/SV, AO |
protective factor |
|
368
|
Low physical HRQoL-Educational level |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
protective factor |
|
369
|
Low physical HRQoL-Maximum physical capacity |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
protective factor |
|
370
|
Low mental HRQoL-social support |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
protective factor |
|
371
|
Impaired poor psychological adjustment-social support |
isolated CHD/non-isolated CHD: BAV/RVSD/MVD/PVS/AVD/ASD/VSD/SVD/PDA/CoA/EA/PS/AVSD/SVAS/HCM/TOF/DORV/RVD/Shone's Complex/PA/ccTGA/TGA/ES/C-CHD/other |
protective factor |
|
422
|
the mutant allete C of 5, 10 methylenetetrahydrofolate reductase (MTHFR) A1298C C |
isolated CHD: ASD/VSD/PDA/TOF/PVS |
protective factor |
|
423
|
the mutant allete AC of 5,10 methylenetetrahydrofolate reductase (MTHFR) A1298C AC |
isolated CHD: ASD/VSD/PDA/TOF/PVS |
protective factor |
|
506
|
2 year cognitive composite score |
isolated CHD/non-isolated CHD: SV/HLHS/Taussig–Bing anomaly/IAA, HAA/CoA, HAA |
protective factor |
|
507
|
6 year full-scale IQ |
isolated CHD/non-isolated CHD: SV/HLHS/Taussig–Bing anomaly/IAA, HAA/CoA, HAA |
protective factor |
|
510
|
basal ganglia and thalamus(BGT) |
isolated CHD/non-isolated CHD: SV/HLHS/Taussig–Bing anomaly/IAA, HAA/CoA, HAA |
protective factor |
|
511
|
brain stem(BS) |
isolated CHD/non-isolated CHD: SV/HLHS/Taussig–Bing anomaly/IAA, HAA/CoA, HAA |
protective factor |
|
543
|
apoferritn levels ng/mL |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PS/AOS/Bc/CoA/D-TGA/ccTGA/TOF/EA/other |
protective factor |
|
548
|
Urban accessibility |
isolated CHD: PDA/ASD/VSD |
protective factor |
|
549
|
LST (Land surface temperature) |
isolated CHD: PDA/ASD/VSD |
protective factor |
|
550
|
Real GDP (Gross domestic product) |
isolated CHD: PDA/ASD/VSD |
protective factor |
|
686
|
Lowset temperature |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
719
|
Pulmonary artery resistance(PAR) |
isolated CHD: CHD with PAH/EA |
protective factor |
|
791
|
Age |
isolated CHD/non-isolated CHD: AV/ASD/VSD/PDA/ASD, VSD, repaired ductus arteriosus/AVSD, ASD/CoA/DORV/PA/TGA/ccTGA/UVA/ES/TOF/EA/other |
protective factor |
|
793
|
age |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
798
|
forced vital capacity(FVC) |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
800
|
independent predictors of a restrictive lung pattern(body mass index, BMI) |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
807
|
independent predictors of an impaired exercise capacity(BMI) |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
808
|
independent predictors of an impaired exercise capacity(sex female) |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
810
|
independent predictors of an impaired exercise capacity: FVC (%predicted) |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
814
|
Predictors of survival in logistic regression model for all 1281 patients with valid cardiopulmonary exercise test(age) |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
815
|
Predictors of survival in logistic regression model for all 1281 patients with valid cardiopulmonary exercise test(thoracotomies) |
isolated CHD/non-isolated CHD: NA |
protective factor |
|
920
|
FIGN +94762G>C(Genotype: GC) (rs2119289)--Shanghai group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
921
|
FIGN +94762G>C(Genotype: CC) (rs2119289)--Shanghai group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
923
|
FIGN +94762G>C(allele: C) (rs2119289)--Shanghai group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
925
|
FIGN +94762G>C(Genotype: GC) (rs2119289)--Shandong group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
926
|
FIGN +94762G>C(Genotype: CC) (rs2119289)--Shandong group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
928
|
FIGN +94762G>C(allele: C) (rs2119289)--Shandong group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
930
|
FIGN +94762G>C(Genotype: GC) (rs2119289)--Anhui group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
931
|
FIGN +94762G>C(Genotype: CC) (rs2119289)--Anhui group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
933
|
FIGN +94762G>C(allele: C) (rs2119289)--Anhui group |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
935
|
FIGN +94762G>C(Genotype: GC) (rs2119289)--Combined |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
936
|
FIGN +94762G>C(Genotype: CC) (rs2119289)--Combined |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
938
|
FIGN +94762G>C(allele: C) (rs2119289)--Combined |
isolated CHD: ASD/VSD/TOF/AVSD/TGA/DOLV/DORV |
protective factor |
|
966
|
GIT symptoms--Diarrhea (Negative, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
967
|
GIT symptoms--Abdominal pain (Positive, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
968
|
GIT symptoms--Abdominal distension (Positive, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
970
|
GIT symptoms--Diarrhea (Negative, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
971
|
GIT symptoms--Abdominal pain (Positive, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
972
|
GIT symptoms--Abdominal distension (Positive, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
974
|
GIT symptoms--Abdominal pain (Positive, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
975
|
GIT symptoms--Abdominal distension (Positive, percent) |
isolated CHD/non-isolated CHD: TOF/TGA/PA, VSD/DORV, MGV/ASD |
protective factor |
|
1012
|
Impaired mental HrQoL(minimally active) |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
protective factor |
|
1013
|
Impaired mental health-related quality of life(HrQoL) |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
protective factor |
|
1014
|
Impaired physical -HrQoL |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
protective factor |
|
1015
|
Impaired exercise capacity |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
protective factor |
|
1016
|
Impaired exercise capacity |
isolated CHD: TOF/PS/AS/CoA/TGA/EA/ASD/VSD/AVSD |
protective factor |
|
1039
|
Predictors of procedural failure--Class III agents |
isolated CHD/non-isolated CHD: ASD/VSD/PAVC/TOF, DORV/PA/EA/L-TGA/APVR/TA/other |
protective factor |
|
1049
|
ABO blood group--isolated CHD |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1050
|
gender (Male vs Female)--isolated CHD |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1051
|
ABO blood group--VSD |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1052
|
ABO blood group--ASD |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1053
|
ABO blood group--PDA |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1054
|
ABO blood group--TOF |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1055
|
ABO blood group--PA |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1056
|
ABO blood group--DORV |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1057
|
ABO blood group--TGA |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1058
|
ABO blood group--COA |
isolated CHD: VSD/ASD/TOF/DORV/CoA/PDA/PA/TGA |
protective factor |
|
1100
|
Age, months |
isolated CHD/non-isolated CHD: TOF/AVC/CoA/IAA/PA/TGA/VSD, ASD/CAT/HLHS/TAPVC/AR/other |
protective factor |
|
1165
|
VIS |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
protective factor |
|
1166
|
Delayed sternal closure--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
protective factor |
|
1167
|
Reintubation--≥72 hr |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
protective factor |
|
1170
|
Weight--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
protective factor |
|
1172
|
VIS--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
protective factor |
|
1173
|
Delayed sternal closure--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
protective factor |
|
1175
|
Respiratory complications--≥7 Days |
isolated CHD/non-isolated CHD: TOF/ASD/VSD with PAH/CAVSD/PS/TA/DORV, PS/TGA/TAPVC/AS, MS/PDA with PAH/other |
protective factor |
|
1258
|
African American–white disparity in neonatal mortality rate due to CHD |
NA: LSOOL/CTDs/RSOOL/SD/AVSD/Lesions of veins/Lesions of arteries |
protective factor |
|
1343
|
Mortality |
isolated CHD: D-TGA/VSD/CHD with PAH |
protective factor |
|
1344
|
Morbidity |
isolated CHD: D-TGA/VSD/CHD with PAH |
protective factor |
|
1348
|
The mWHO risk classification |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
protective factor |
|
1349
|
ZAHARA score |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
protective factor |
|
1350
|
CARPREG score |
isolated CHD/non-isolated CHD: ASD/VSD/AVSD/PDA/MVS/MP/BAV/AS/PS/DPA/TS/TOF/EA/NA/TGA/TAPVD |
protective factor |
|
1460
|
Age |
isolated CHD/non-isolated CHD: C-CHD/non C-CHD |
protective factor |
|
1461
|
Weight |
isolated CHD/non-isolated CHD: C-CHD/non C-CHD |
protective factor |
|
1462
|
Hospital stay duration |
isolated CHD/non-isolated CHD: C-CHD/non C-CHD |
protective factor |
|
1463
|
cyanotic congenital cardiac disease |
isolated CHD/non-isolated CHD: C-CHD/non C-CHD |
protective factor |
|
1493
|
serum insulin |
isolated CHD: D-TGA |
protective factor |
|
1503
|
cyanotic ACHD |
isolated CHD/non-isolated CHD: ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
protective factor |
|
1524
|
GDF-15 |
isolated CHD/non-isolated CHD: AS/AC/TOF/TGA/ccTGA/NA/PAH/TGA, VSD, DORV |
protective factor |
|
1548
|
P-selectin candidate gene SNPs---827T/C:CT |
isolated CHD: ASD/PDA/VSD |
protective factor |
|
1549
|
P-selectin candidate gene SNPs---827T/C:CT+CC |
isolated CHD: ASD/PDA/VSD |
protective factor |
|
1551
|
P-selectin candidate gene SNPs---827T/C:CT |
isolated CHD: ASD/PDA/VSD |
protective factor |
|
1552
|
P-selectin candidate gene SNPs---827T/C:CT+CC |
isolated CHD: ASD/PDA/VSD |
protective factor |
|
1724
|
Correlation: NLR (neutrophil to lymphocyte ratio)--PPAP |
isolated CHD/non-isolated CHD: VSD/p-AVSD/VSD, PDA/VSD, SAS/DORV/TAPVC/CAVSD/TA/MS, VSD |
protective factor |
|
1725
|
Correlation: CRP (C-reactive protein)--PPAP(mean pulmonary artery pressure) |
isolated CHD/non-isolated CHD: VSD/p-AVSD/VSD, PDA/VSD, SAS/DORV/TAPVC/CAVSD/TA/MS, VSD |
protective factor |
|
1726
|
Correlation: Patient age--PPAP |
isolated CHD/non-isolated CHD: VSD/p-AVSD/VSD, PDA/VSD, SAS/DORV/TAPVC/CAVSD/TA/MS, VSD |
protective factor |
|
1727
|
Correlation: NLR (neutrophil to lymphocyte ratio)--mPAP |
isolated CHD/non-isolated CHD: VSD/p-AVSD/VSD, PDA/VSD, SAS/DORV/TAPVC/CAVSD/TA/MS, VSD |
protective factor |
|
1728
|
Correlation: CRP (C-reactive protein)--mPAP |
isolated CHD/non-isolated CHD: VSD/p-AVSD/VSD, PDA/VSD, SAS/DORV/TAPVC/CAVSD/TA/MS, VSD |
protective factor |
|
1729
|
Correlation: Patient age--mPAP |
isolated CHD/non-isolated CHD: VSD/p-AVSD/VSD, PDA/VSD, SAS/DORV/TAPVC/CAVSD/TA/MS, VSD |
protective factor |
|
1748
|
incidence of TA, tachyarrhythmia |
NA: NA |
protective factor |
|
1749
|
incidence of TA receiving intervention |
NA: NA |
protective factor |
|
1750
|
incidence of BA,bradyarrhythmia |
NA: NA |
protective factor |
|
1751
|
incidence of BA receiving intervention |
NA: NA |
protective factor |
|
1752
|
incidence of JET,junctional ectopic tachycardia |
NA: NA |
protective factor |
|
1753
|
incidence of JET receiving intervention |
NA: NA |
protective factor |
|
1824
|
serum Cys C levels |
NA: NA |
protective factor |
|
1836
|
younger age groups at the time of surgery |
isolated CHD/non-isolated CHD: HOCM, SAS, DCRV/VSD/D-TGA, VSD, PS, TVD/MS/DORV, TGA, VSD/ccTGA, PA, VSD/AVSD/AA, VSD, ASD, CoA |
protective factor |
|
1868
|
calcium supplement during early pregnancy |
isolated CHD: ASD/VSD/other |
protective factor |
|
1871
|
systemic atery systolic blood pressure(SBP) |
isolated CHD/non-isolated CHD: ASD/VSD/PDA/NA |
protective factor |
|
1893
|
Year of catheterization |
isolated CHD: PDA/ASD/PV/PAS/TGA/CoA/PFO/AVS/PA/TOF/DORV/UVH/VSD/other |
protective factor |
|
1916
|
WHO class |
isolated CHD: ASD/VSD/AVSD/APVR/PS/AVS/BAV/AC/EA/TOF/TGA/other |
protective factor |
|
1917
|
ZAHARA I risk score |
isolated CHD: ASD/VSD/AVSD/APVR/PS/AVS/BAV/AC/EA/TOF/TGA/other |
protective factor |
|
1918
|
Composite ROC [optimal combination of risk assessment models (WHO class, total no. cardiovascular predictors and disease complexity)]. |
isolated CHD: ASD/VSD/AVSD/APVR/PS/AVS/BAV/AC/EA/TOF/TGA/other |
protective factor |
|
1919
|
total no. cardiovascular predictors |
isolated CHD: ASD/VSD/AVSD/APVR/PS/AVS/BAV/AC/EA/TOF/TGA/other |
protective factor |
|
1920
|
disease complexity |
isolated CHD: ASD/VSD/AVSD/APVR/PS/AVS/BAV/AC/EA/TOF/TGA/other |
protective factor |
|
1921
|
the total number of cardiovascular (TPc) or offspring risk predictors (TPo) |
isolated CHD: ASD/VSD/AVSD/APVR/PS/AVS/BAV/AC/EA/TOF/TGA/other |
protective factor |
|
1949
|
predictor of unscheduled hospitalization: Peak VO2(per 1.0ml/kg/min) |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
protective factor |
|
1951
|
predictor of unscheduled hospitalization: Atrerial oxygen saturation |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
protective factor |
|
1964
|
predictor of mortality: Peak VO2(per 1.0ml/kg/min) |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
protective factor(univariate model) |
|
1965
|
predictor of mortality: Atrerial oxygen saturation |
isolated CHD/non-isolated CHD: TA/UVH/DORV/PA/MA/TOF/AVD/CoA, IAA/VSD/TGA/other |
protective factor(univariate model) |
|
2031
|
Hcy(predict dynamic and obstructive PH) |
isolated CHD: VSD/ASD/PDA/PAH/ES |
protective factor |
|
2032
|
H2S( predict dynamic and obstructive PH) |
isolated CHD: VSD/ASD/PDA/PAH/ES |
protective factor |
|
2033
|
CSE expression(predict dynamic and obstructive PH) |
isolated CHD: VSD/ASD/PDA/PAH/ES |
protective factor |
|
2109
|
physical exercise>3h/week |
isolated CHD: AVD |
protective factor |
|
2340
|
GGC repeat ≥13 |
NA: CHD with PAH |
protective factor |
|
2368
|
Correlation between exercise time and maternal events |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
protective factor |
|
2369
|
Correlation between peak HR and maternal events |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
protective factor |
|
2370
|
Correlation between peak SBP (systolic blood pressure) and maternal events |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
protective factor |
|
2371
|
Correlation between peak oxygen uptake and maternal events |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
protective factor |
|
2372
|
Correlation between exercise time and neonatal events |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
protective factor |
|
2373
|
Correlation between anaerobic threshold (Oxygen uptake) and neonatal events |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
protective factor |
|
2374
|
Correlation between peak Oxygen uptake and neonatal events |
isolated CHD/non-isolated CHD: ASD/VSD/AVS/PVS/CoA/TOF/TOF, PA/ccTGA/TGA/EA/DORV/TAPVC/PA, IVS/TGA/TA |
protective factor |
|
2449
|
Relative importance of individual symptom to perceived health：male |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2450
|
Relative importance of individual symptom to perceived health：age |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2451
|
Relative importance of individual symptom to perceived health：NYHA-II |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2452
|
Relative importance of individual symptom to perceived health：NYHA-III |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2453
|
Relative importance of individual symptom to perceived health：NYHA-IV |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2454
|
Relative importance of individual symptom to perceived health：Shortness of breath walking 1-5 km |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2455
|
Relative importance of individual symptom to perceived health：Orthopnea |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2456
|
Relative importance of individual symptom to perceived health：Nycturia |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2457
|
Relative importance of individual symptom to perceived health：Palpitations |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2458
|
Relative importance of individual symptom to perceived health：Dizziness |
isolated CHD/non-isolated CHD: VSD, ASD, ASDI, PDA/TOF, PS/BAV, AS, SVAS/CoA/TGA/other |
protective factor |
|
2460
|
Relationship between symptom distress and perceived health |
NA: NA |
protective factor |
|
2461
|
Factor related the surgical success rate for PDA: PDA size |
isolated CHD: PDA |
protective factor |
|
2462
|
Factor related the surgical success rate for PDA: procedure time |
isolated CHD: PDA |
protective factor |
|
2465
|
Factor related the surgical success rate and complications for ASD: ASD maximal size |
isolated CHD: ASD |
protective factor |
|
2466
|
Factor related the surgical success rate and complications for ASD: procedure time |
isolated CHD: ASD |
protective factor |
|
2472
|
Risk factor related the occurrence of complications for PBPV: Body weight |
isolated CHD: PS |
protective factor |
|
2511
|
BMI (>25) |
NA: NA |
protective factor |
|
2512
|
BMI (21-25) (reference=BMI<21) |
NA: NA |
protective factor |
|
2642
|
age (months) |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
protective factor |
|
2644
|
Weight (kg) |
isolated CHD: HLHS/AVC/VSD/CoA/SASD/DORV/TOF/AS/PASD/TA |
protective factor |
|
2724
|
Age at implantation (years) |
isolated CHD: LVOTO/ASD/VSD/AVSD/TGA/TOF/other |
protective factor |
|
2740
|
logistic regression analysis and risk of mortality: Weight (kg)(neonates≤30 days) |
isolated CHD: PA/VSD/ASD/TA/AVSD/TAPVC/other |
protective factor |
|
2752
|
Age (y)(risk factors associated with redo PVR) |
isolated CHD/non-isolated CHD: TOF/PA, VSD/DORV/TGA/PS/other |
protective factor |
|
2874
|
CPB time (min) |
isolated CHD/non-isolated CHD: AS, VSD/TCPC/PA, VSD/AVSD/PA, EA/DORV, VSD/PA, IVS/TAPVD/other |
protective factor |
|
2894
|
lowest SaO2(arterial oxygen saturation) |
isolated CHD: TGA/SV |
protective factor |
|
2975
|
preoperative NYHA class I |
isolated CHD/non-isolated CHD: ASD/VSD/PAPVC/p-AVSD/TGA, IVS/EA/CoA/VPS/SAS/SPS/AI/other |
protective factor |
|
2976
|
surgery for 'septal defect'(ASDs,VSDs,AVSDs) |
isolated CHD/non-isolated CHD: ASD/VSD/PAPVC/p-AVSD/TGA, IVS/EA/CoA/VPS/SAS/SPS/AI/other |
protective factor |
|
3110
|
correlation between younger maternal age (per year) and obstetric complications |
isolated CHD/non-isolated CHD: ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
protective factor |
|
3113
|
correlation between oxygen saturation and obstetric complications |
isolated CHD/non-isolated CHD: ASD/VSD/AVC/PS/PA, RV to PAC/DCRV, VSD/AS/AC/TOF/D-TGA, VSD, PS/ccTGA/SV/EA |
protective factor |
|
3140
|
Mother's education level |
isolated CHD: VSD/PDA/TOF/ASD/PS/other |
protective factor |
|
3244
|
weight (per kilo) |
isolated CHD/non-isolated CHD: HLHS/VSD, PS/UVH, PS/PATR, TOF/UVH/CAT/CAT, IAA/VSD, ASDII/AVSD/VSD, ASD/TGA, AVSD, IAA/AVSD/IAA, VSD, ASD/HLHS/AVSD/TGA, PATR, VSD/TGA/VSD/AVSD/TAPVD/DORV/other |
protective factor |
|
3264
|
surgical intervention |
isolated CHD/non-isolated CHD: VSD/VSD, ASD/VSD, PDA/MS/AS/CoA, VSD/CoA/ccTGA/EA/DORV/TOF/ccTGA/ASD/CAT/ccTGA, VSD, PS/TS, HRV, PS/AVAS/other |
protective factor |
|
3265
|
age < 0.1 year |
NA: NA |
protective factor |
|
3268
|
calender year 1997-99 |
NA: NA |
protective factor |
|
3269
|
calender year 2000-02 |
NA: NA |
protective factor |
|
3344
|
Aristotle<14 |
isolated CHD/non-isolated CHD: SV/HLHS/PA, IVS/AVC/CAT/TOF/DORV/TAPVC/IAA, VSD/PA, VSD |
protective factor |
|
3363
|
complication rates |
isolated CHD/non-isolated CHD: PA/MAPCA/arterial duct/Systemic vein/RVOTO, pulmonary trunk/APS/PV/CACA/other |
protective factor |
|
3380
|
Heart rate reserve (10 beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3381
|
Chronotropic index |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3382
|
Peak heart rate (10 beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3383
|
percentage predicted peak heart rate |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3384
|
heart rate recovery 1 minute (beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3385
|
heart rate recovery 2 minute (beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3386
|
heart rate recovery 3 minute (beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3387
|
heart rate recovery 5 minute (beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3388
|
Peak VO2 (ml/kg/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3394
|
Heart rate reserve (10 beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3397
|
Heart rate reserve (10 beats/min) |
isolated CHD/non-isolated CHD: ASD/ccTGA/CoA/other/EA/ES/TOF/VSD |
protective factor |
|
3410
|
Parents' highest education high school graduate or less |
NA: NA |
protective factor |
|
3438
|
Peak VO2 |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
protective factor |
|
3439
|
peak heart rate |
isolated CHD/non-isolated CHD: ASD/AVSD/ccTGA/CoA/other/EA/ES/TOF/CHD with PAH/VSD |
protective factor |
|
3527
|
CHD recognition route C versus A (outcome 2 measured by death) |
isolated CHD/non-isolated CHD: LHO/TGA/PA/SV/TAPVC/other |
protective factor |
|
3940
|
association with age and recrational drug use |
NA: NA |
protective factor |
|
3941
|
association with sex and recrational drug use |
NA: NA |
protective factor |
|
3945
|
association between sports participation with age |
NA: NA |
protective factor |
|
3946
|
association with sports participation with defect complexity |
NA: NA |
protective factor |
|
3947
|
association with sports participation with sex |
NA: NA |
protective factor |
|
3951
|
association with sports participation with cardiac defect functional status |
NA: NA |
protective factor |
|
3952
|
white |
isolated CHD: SV dd-SBF/BiV dd-SBF/D-TGA/BiV dd-PBF/SV dd-PBF/SV/TA/other |
protective factor |
|
3955
|
exclusively unfortified HMD(human milk diet) |
isolated CHD: SV dd-SBF/BiV dd-SBF/D-TGA/BiV dd-PBF/SV dd-PBF/SV/TA/other |
protective factor |
|
3970
|
low T1(baseline) PHC(perveived health competence) |
NA: NA |
protective factor |
|
3971
|
low T1(baseline) PHC(perveived health competence) |
NA: NA |
protective factor |
|
4076
|
age(days)(infants) |
NA: NA |
protective factor |
|
4080
|
BMI(5th~95th percentile)(infants) |
NA: NA |
protective factor |
|
4084
|
Lymphocyte count(>cut off value)(infants) |
NA: NA |
protective factor |
|
4087
|
Lymphocytes/WBC(>cut off value)(infants) |
NA: NA |
protective factor |
|
4088
|
Neutrophils/WBC(<cut off value)(infants) |
NA: NA |
protective factor |
|
4098
|
Lymphocyte count(>cut off value)(children) |
NA: NA |
protective factor |
|
4100
|
Lymphocytes/WBC(>cut off value)(children) |
NA: NA |
protective factor |
|
4119
|
Food types eaten 3 or more times per week(Oranges, strawberries, raspberries, pineapple, kiwi, cantaloupe, lemons, limes) |
isolated CHD/non-isolated CHD: anomalies of the venous return/ASD/AVSD, OPD/AVC/HLHS/VSD/TOF, TGA/CoA/CACA |
protective factor |
|
4128
|
age |
NA: NA |
protective factor |
|
4139
|
ventricular level shunt(left-to-right) |
NA: NA |
protective factor |
|
4143
|
pulmonary insufficiency(PI)(minimal) |
NA: NA |
protective factor |
|
4184
|
risk of preterm birth of different age(<25 years) |
isolated CHD: NA |
protective factor |
